Home > About Us > Our Team

Our Team

Our team is comprised of Wall Street investment professionals with experience in biotechnology sellside and buyside equity research, institutional equity sales, healthcare investment banking and hedge fund portfolio management. Our team also has organic chemistry research experience in academia and at pharmaceutical and biotechnology companies.

  • Andrew I. McDonald, Ph.D.

  • Myles Blechner

  • Michael Rice

  • Paul Yook